Lakkireddy et al. found that COVID-19 patients with hypovitaminosis D had evaluated IL6 levels and IL6 levels were reduced in patients supplemented with 60,000 IUs/daily of vitamin D for 8–10 days compared with the patients who received standard treatment [49]. Here, IL6 is linked to COVID-19.